SCHEMBL31415554

SCHEMBL31415554

Cc1noc(-c2cc(N)ccc2C)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.59
PIK3CG P48736 13/20 0.48
PIK3CD O00329 12/20 0.48
MTOR P42345 6/20 0.48
KDM4E B2RXH2 2/20 0.47
MAPT P10636 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HSD17B10 Q99714 2/20 0.47
ALDH1A1 P00352 2/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
PIK3CB P42338 10/20 0.41
PLA2G7 Q13093 1/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218113 0.87 ACHE (0.71) ACHEPIK3CGPIK3CDMTORMAPT
SCHEMBL21939240 0.86 ACHE (0.59) ACHEPIK3CGPIK3CDMTORKDM4E
SCHEMBL16481865 0.82 RAB9A (0.46) ACHEPIK3CGPIK3CDMTORKDM4E
SCHEMBL21939273 0.80 ACHE (0.56) ACHEPIK3CGPIK3CDMTORRAB9A
SCHEMBL31415598 0.80 RAB9A (0.42) ACHEPIK3CGPIK3CDMTORKDM4E
SCHEMBL12909247 0.79 ACHE (0.46) ACHEPIK3CGPIK3CDMTORMAPT
SCHEMBL964682 0.78 ACHE (0.53) ACHEKDM4EMAPTRAB9ASMN1; SMN2
SCHEMBL16481829 0.77 NR1H4 (0.48) ACHEPIK3CGPIK3CDMTORKDM4E
SCHEMBL31415531 0.76 ALDH1A1 (0.47) ACHEKDM4EMAPTRAB9ASMN1; SMN2
SCHEMBL981283 0.74 ACHE (1.00) ACHEKDM4EMAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054368-A1 COMPOUNDS, COMPOSITIONS, AND METHODS NICO THERAPEUTICS, INC. (US) 2025-03-13 WO disclosed